Valuation Shanghai Rendu Biotechnology Co., Ltd.
Stocks
688193
CNE1000059K5
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Shanghai S.E.
2026-09-30
|
5-day change | 1st Jan Change | ||
| 52.19 CNY | +4.46% |
|
+6.12% | +7.90% |
| 08-28 | Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-14 | Shanghai Rendu Biotechnology's share trade to resume from May 15 | RE |
Company Valuation: Shanghai Rendu Biotechnology Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 1,869 | 1,805 | 1,384 | 1,876 |
| Change | - | -3.42% | -23.32% | 35.54% |
| Enterprise Value (EV) 1 | 1,049 | 1,026 | 586.3 | 1,061 |
| Change | - | -2.19% | -42.87% | 80.99% |
| P/E | 76.6x | 215x | -179x | 186x |
| PBR | 1.94x | 1.87x | 1.52x | 2.05x |
| PEG | -1.1x | -3.3x | 1x | -1x |
| Capitalization / Revenue | 6.15x | 11x | 7.8x | 11.6x |
| EV / Revenue | 3.45x | 6.24x | 3.31x | 6.55x |
| EV / EBITDA | 60.2x | -76.4x | -28.1x | 131x |
| EV / EBIT | 209x | -39.1x | -16.8x | -197x |
| EV / FCF | -35.3x | -99x | 31.9x | 69.9x |
| FCF Yield | -2.83% | -1.01% | 3.14% | 1.43% |
| Dividend per Share 2 | 0.125 | 0.2 | 0.2 | 1.15 |
| Rate of return | 0.27% | 0.44% | 0.56% | 2.38% |
| EPS 2 | 0.61 | 0.21 | -0.2 | 0.26 |
| Distribution rate | 20.5% | 95.2% | -100% | 442% |
| Net sales 1 | 303.8 | 164.4 | 177.4 | 161.9 |
| EBITDA 1 | 17.42 | -13.43 | -20.86 | 8.096 |
| EBIT 1 | 5.018 | -26.23 | -34.98 | -5.382 |
| Net income 1 | 23.33 | 8.259 | -7.812 | 10.09 |
| Net Debt 1 | -819.4 | -778.4 | -797.5 | -814.5 |
| Reference price 2 | 46.72 | 45.12 | 35.75 | 48.37 |
| Nbr of stocks (in thousands) | 40,000 | 40,000 | 38,709 | 38,778 |
| Announcement Date | 4/25/23 | 4/29/24 | 4/29/25 | 4/28/26 |
1CNY in Million2CNY
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 302M | |
| 27.63x | 3.84x | 14.83x | 2.64% | 169B | |
| 18.25x | 3.37x | 12.04x | 3.26% | 110B | |
| 21.42x | 4.21x | 14.72x | 1.31% | 106B | |
| 25.26x | 2.48x | 10.04x | 2.86% | 73.87B | |
| 16.92x | 0.2x | 12.42x | 0.77% | 58.98B | |
| 29.48x | 7.29x | 18.84x | 1.36% | 51.28B | |
| 34.07x | 3.32x | 11.38x | 2.22% | 48.16B | |
| 35.11x | 8.73x | 24.55x | -.--% | 40.84B | |
| 34.3x | 6.01x | 18.87x | -.--% | 32.21B | |
| Average | 26.94x | 4.38x | 15.30x | 1.6% | 69.05B | |
| Weighted average by Cap. | 25.35x | 3.98x | 14.47x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 688193 Stock
- Valuation Shanghai Rendu Biotechnology Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
